Your browser doesn't support javascript.
loading
Different Approaches to Atopic Dermatitis by Allergists, Dermatologists, and Pediatricians.
Zuccolo de Bortoli, Suzieni Padoin; Chong Neto, Herberto José; Rosário Filho, Nelson Augusto.
Afiliação
  • Zuccolo de Bortoli SP; Federal University of Parana, Parana, Brazil.
  • Chong Neto HJ; Pediatric Allergy and Immunology, Federal University of Parana, Parana, Brazil.
  • Rosário Filho NA; Pediatric Allergy and Immunology, Federal University of Parana, Parana, Brazil.
Dermatol Res Pract ; 2021: 6050091, 2021.
Article em En | MEDLINE | ID: mdl-34899901
ABSTRACT

OBJECTIVES:

Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease, with a vast drug arsenal and guidelines available for its management and diagnosis and different medical specialties engaged in providing care. This study aimed to outline the therapeutic and diagnostic approaches to the AD of allergists, dermatologists, and pediatricians and verify whether they are compliant with the guidelines.

METHODS:

A cross-sectional study using an electronic questionnaire administered through the SurveyMonkey® platform was disclosed by participating medical societies to their medical associates.

RESULTS:

Of the 1,473 participating physicians, the use of moisturizers as part of AD treatment was observed among pediatricians (91.9%), dermatologists (97.5%), and allergists (100%; p=0.07). The preference for the use of new emollients was lower among pediatricians (57%) than dermatologists (75.9%) and allergists (71.4%; p < 0.001). The prevalence of wet-wrap therapy was lower among dermatologists (16.3%) than allergists (51%; p < 0.001). The recommendation of proactive treatment with topical corticosteroids was more frequently reported by allergists (65.3%) than pediatricians (43.3%) and dermatologists (40.8%; p < 0.001), and the same trend was observed in relation to proactive treatment using calcineurin inhibitors. The use of oral anti-histamines to control pruritus was mainly considered by pediatricians (69.2%) and dermatologists (59.2% p < 0.001). Clinical experience with systemic immunomodulating agents was greater among allergists (77.5%) and dermatologists (60.8%; p < 0.001), with cyclosporine being the most cited systemic immunomodulating agent. Environmental control of aeroallergens was recommended by pediatricians (89.8%), dermatologists (86.9%), and allergists (100%; p=0.01).

CONCLUSION:

There were differences in the therapeutic and diagnostic approaches to AD used by allergists, dermatologists, and pediatricians and those recommended by the guidelines, especially regarding the use of wet-wrap therapy, proactive treatment with topical corticosteroids or calcineurin inhibitors, prescription of anti-histamines, recommendation of phototherapy, and control of aeroallergens.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Dermatol Res Pract Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Dermatol Res Pract Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil